Helping journalists, producers and conference planners find the female guests, speakers and expert sources they need.

Dr. Jen Gommerman

Professor, University of Toronto, Department of Immunology

Immunology, Multiple Sclerosis, gut-brain axis, COVID-19, COVID-19 vaccine


Dr. Jennifer Gommerman

A brief overview of Dr. Gommerman, her research and the trainees in her lab

New reports show coronavirus immunity can last for months

Will vaccines stop the spread of COVID-19? How long will protection last? Success may delay answers

Scientists probe the mysteries of COVID-19 immunity

‘Natural Immunity’ From Covid Is Not Safer Than a Vaccine

Plasma Cells in the Gut May Actually Help Fight MS

Gut immune cells cut inflammation in multiple sclerosis

19 antibodies last at least 3 months; so do symptoms for many

Scientists find signs of waning antibody immunity to COVID-19 over time in England

COVID-19 infection vs. vaccination: Which is better for immunity?

How does the body fight COVID-19? U of T researcher's work could aid vaccine development


Dr. Jen Gommerman received her Ph.D. in Immunology at the University of Toronto in 1998. She went on to do a post-doctoral fellowship at Harvard Medical School and then joined Biogen Inc. as a Staff Scientist in 2000. After three years in Industry, she returned to academia as an assistant professor (Immunology) at the University of Toronto in 2003, in 2015 was promoted to full professor, and in 2020 was awarded a Tier I Canada Research Chair in Tissue Specific Immunity. Gommerman's basic research focuses on autoimmunity, particularly the disease Multiple Sclerosis. More recently she has been studying the antibody response to SARS-CoV-2 in patients with COVID-19.


  • immunology
  • Multiple Sclerosis
  • gut-brain axis
  • COVID-19
  • COVID-19 vaccine

Sign up to receive workshop notifications, occasional blog posts and our quarterly newsletter

JOURNALISTS: Sign up to receive alerts for sources for breaking news stories